Lewis et al. showed that overexpression of human apoA-I is effective to preserve cognitive function in a mouse model of Alzheimer's disease through reducing Aβ-induced production of chemokines/cytokines [45]. Here, APOA1 is linked to early-onset autosomal dominant Alzheimer disease.